Medistim ASAFRA:MD1 +1.46%100 Days Inventory is 345.76 as of Mar. 2026, which is 9% below its 10-year median of 378.85. GuruFocus rates FRA:MD1 with a GF Score™ of 100/100 and a GF Value™ of €23.06 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 785 Medical Devices & Instruments companies, Medistim ASA ranks worse than 88.03% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Medistim ASA's Average Total Inventories for the
three
months ended in Mar. 2026 was €13.99 Mil. Medistim ASA's Cost of Goods Sold for the
three
months ended in Mar. 2026 was €3.69 Mil.
Hence, Medistim ASA's Days Inventory for the
three
months ended in Mar. 2026 was 345.76.
The historical rank and industry rank for Medistim ASA's Days Inventory or its related term are showing as below:
FRA:MD1'
s Days Inventory Range Over the Past 10 Years
Min: 290.98 Med: 378.85 Max: 491.11
Current: 436.77
During the past 13 years, Medistim ASA's highest Days Inventory was 491.11. The lowest was 290.98. And the median was 378.85.
FRA:MD1's Days Inventory is ranked worse than 88.03% of 785
companies
in the Medical Devices & Instruments industry
Industry Median: 179.47
vs FRA:MD1: 436.77
Medistim ASA's Days Inventory
declined
from Mar. 2025 (485.95) to Mar. 2026 (345.76).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Medistim ASA's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.26.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Medistim ASA's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.77.
Medistim ASA (FRA:MD1) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Medistim ASA's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Medistim ASA's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Medistim ASA Days Inventory Related Terms
Medistim ASA Days Inventory Historical Data
* Premium members only.
The historical data trend for Medistim ASA's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:MD1 vs ABT, SYK, MDT: Days Inventory Comparison
For the Medical Devices subindustry, Medistim ASA's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medistim ASA Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medistim ASA's Days Inventory distribution charts can be found below:
* The bar in red indicates where Medistim ASA's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medistim ASA (FRA:MD1) has a Days Inventory of 345.76 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Medistim ASA and its competitors. This is near median its historical median of 378.85. Over the past decade, Medistim ASA's Days Inventory has ranged from 290.98 to 491.11. According to the industry distribution chart, Medistim ASA ranks #691 out of 785 companies in the Medical Devices & Instruments industry, placing it in the top 88%.
Is Medistim ASA's Days Inventory too high?
Medistim ASA's current Days Inventory of 345.76 is near median its 10-year median of 378.85. Over the past 10 years, this metric has ranged from a low of 290.98 to a high of 491.11. The Medical Devices & Instruments industry median Days Inventory is 179.47. Medistim ASA's value of 345.76 is 92.7% above this industry median. Based on the distribution chart, Medistim ASA ranks #691 out of 785 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Medistim ASA has a GF Score™ of 100/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medistim ASA's Days Inventory compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Medistim ASA ranks #691 out of 785 companies for Days Inventory. This places Medistim ASA in the lower half of its industry. The industry median Days Inventory is 179.47. Medistim ASA's value of 345.76 is 92.7% above this benchmark. Historically, Medistim ASA's own Days Inventory has ranged from 290.98 to 491.11 over the past decade. While the company's 10-year median is 378.85 vs. the industry median of 179.47, Medistim ASA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 179.47, based on 785 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medistim ASA's current Days Inventory of 345.76 is 92.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Medistim ASA and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 179.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medistim ASA's current Days Inventory is 345.76, which is near median its own 10-year median of 378.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medistim ASA stock overvalued right now?
Based on GuruFocus' analysis, Medistim ASA (FRA:MD1) is currently considered Modestly Undervalued. The stock's GF Value™ is €23.06, compared to a current price of €20.80 — trading 9.8% below its estimated fair value. The current Days Inventory is 345.76, which is near median its 10-year median of 378.85 and 92.7% above the Medical Devices & Instruments industry median of 179.47. Medistim ASA's overall GF Score™ is 100/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Medistim ASA (FRA:MD1), the current Days Inventory is 345.76 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medistim ASA (FRA:MD1) Overvalued in 2026?
Based on GuruFocus' analysis, Medistim ASA stock appears to be undervalued.
The current stock price of €20.80 is trading 9.8% below its estimated GF Value™ of €23.06.
GuruFocus considers Medistim ASA to be Modestly Undervalued.
Key valuation signals for FRA:MD1:
Days Inventory: 345.76 (near median its 10-year median of 378.85)
GF Value™: €23.06 vs. price of €20.80 (9.8% below fair value)
Industry Position: 92.7% above the Medical Devices & Instruments median (#691 of 785)
No single metric tells the full story. See the FRA:MD1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medistim ASA is a medical device company. It is engaged in researching, developing, producing, distributing, and sales of medical equipment through its own business or participation in other companies, as well as related activities. The company's business is focused on cardiac and vascular surgery. The group operates in the USA, Europe, China, and the Rest of the World. The main divisions are sale of own products and sale of third-party products. Sale of own products has two business models, the capital model and the lease model. Third-party products segment sells medical devices from third party manufacturers in Norway, Sweden and Denmark. Key revenue is generated from Own Products segment.
100GF Score
Get the complete analysis for FRA:MD1
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:MD1 has been successfully added to your 
